RARA CRAFT DATABASE for FDA Medical Devices
510(k)K243959

FDA DEVICE FACTS

Powder Free Nitrile Examination Gloves (Violet, Black, Green), Tested for Use with Chemotherapy Drugs, Fentanyl Citrate and Select Other Drugs

Lingshi Hongruida Health Protection Technology Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEFebruary 24, 2025PRODUCT CODELZC

Indications for use

The glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. Gloves have been tested for use with chemotherapy drugs, Fentanyl Citrate and Other Select Drugs using ASTM D6978- 05(2019) Chemotherapy Drug & Concentration Minimum Breakthrough Detection Time in Minutes Violet Black Green Bleomycin Sulfate 15mg/ml (15000 ppm) >240 >240 >240 Busulfan 6mg/ml (6,000 ppm) >240 >240 >240 Carboplatin 10mg/ml (10,000 ppm) >240 >240 >240 Carmustine 3.3 mg/ml (3,300 ppm) 15.3 12.6 11.7 Cisplatin 1mg/ml (1,000 ppm) >240 >240 >240 Cyclophosphamide 20mg/ml (20,000 ppm) >240 >240 >240 Cytarabine, 100 mg/ml (100,000 ppm) >240 >240 >240 Dacarbazine 10 mg/ml (10,000 ppm) >240 >240 >240 Daunorubicin HCL, 5 mg/ml (5,000 ppm) >240 >240 >240 Docetaxel , 10 mg/ml (10,000 ppm) >240 >240 >240 Doxorubicin HCL, 2 mg/ml (2,000 ppm) >240 >240 >240 Epirubicin HCL, 2 mg/ml (2,000 ppm) >240 >240 >240 Etoposide, 20 mg/ml (20,000 ppm) >240 >240 >240 Fludarabine, 25 mg/ml (25,000 ppm) >240 >240 >240 Fluorouracil, 50mg/ml (50,000ppm) >240 >240 >240 Gemcitabine, 38mg/ml (38,000ppm) >240 >240 >240 Idarubicin HCL, 1mg/ml (1,000ppm) >240 >240 >240 Ifosfamide, 50mg/ml (50,000ppm) >240 >240 >240 Irinotecan HCL, 20mg/ml (20,000ppm) >240 >240 >240 Mechlorethamine HCI, 1mg/ml (1,000ppm) >240 >240 >240 Melphalan HCL, 5mg/ml (5,000ppm) >240 >240 >240 Methotrexate, 25mg/ml (25,000ppm) >240 >240 >240 Mitomycin C, 0.5mg/ml (500ppm) >240 >240 >240 Mitoxantrone HCL, 2mg/ml (2,000ppm) >240 >240 >240 Oxaliplatin, 5mg/ml (5,000ppm) >240 >240 >240 Paclitaxel, 6mg/ml (6,000ppm) >240 >240 >240 Paraplatin, 10mg/ml (10,000ppm) >240 >240 >240 Rituximab, 10mg/ml (10,000ppm) >240 >240 >240 Thiotepa, 10mg/ml (10,000ppm) 36.4 15.4 33.0 Topotecan HCL, 1mg/ml (1,000ppm) >240 >240 >240 Trisenox (Arsenic Trioxide), 1mg/ml (1,000ppm) >240 >240 >240 Velcade (Bortezomib) 1mg/ml (1,000ppm) >240 >240 >240 Vincristine Sulfate, 1mg/ml (1,000ppm) >240 >240 >240 Fentanyl Citrate & Other Drugs Minimum Breakthrough Detection Time in Minutes Violet Black Green Fentanyl Citrate Injection, 100mcg/2mg >240 >240 >240 Chloroquine 50mg/ml (50,000ppm) >240 >240 >240 Cyclosporin A 100 mg/ml (100,000 ppm) >240 >240 >240 Retrovir, 10mg/ml (10,000ppm) >240 >240 >240 *Please note that the following drugs have extremely low permeation times: Carmustine: 15.3 minutes, Thiotepa: 36.4 minutes (Violet); Carmustine: 12.6 minutes, Thiotepa: 15.4 minutes (Black); Carmustine: 11.7 minutes, Thiotepa: 33.0 minutes (Green); Warning: Do not use with Carmustine and Thiotepa.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 1, 2026